Trending Now
Dare Bioscience Inc. (NASDAQ: DARE) Announces XACIATO Approval By The FDA...
Dare Bioscience Inc. (NASDAQ: DARE) has announced that the FDA has approved XACIATO (clindamycin phosphate vaginal gel, 2%), which was formerly called DARE-BV1, for...
Humanigen Inc. (NASDAQ: HGEN) Announces Strategic Realignment To Expedite Lenzilumab Development...
Humanigen Inc. (NASDAQ: HGEN) has announced the strategic realignment of its resources and pipeline in a bid to achieve its main clinical milestone. The...
IVERIC Bio Inc (NASDAQ: ISEE) Announces License Agreement With DelSiTech Ltd...
IVERIC Bio Inc (NASDAQ: ISEE) has announced a global license agreement with DelSiTech Ltd, which will offer Iveric Bio the right to create and...
Popular News
Four Top “Healthy Living” Stocks (WW, PLNT, GTEH, MED)
Without doubt, one of the defining trends shaping the coming decade in asset markets is an increased focus on healthy lifestyles. People are simply...
MAKE IT MODERN
LATEST REVIEWS
Redbox (RDBX) Surges On Retail Traders Interest
Shares of Redbox Entertainment Inc (RDBX) are through the roof today potentially due to increased interest from retail traders. The shares have already registered over...
MAKE IT MODERN
PERFORMANCE TRAINING
Lineage Cell Therapeutics Inc. (NYSEAMERICAN:LCTX) Endorses Proposition 14 and Announces Completion of Enrolment...
Lineage Cell Therapeutics Inc. (NYSEAMERICAN:LCTX) has endorsed the recently passed proposition 14 in California.
Lineage endorses the passing of...
British Journal of Haematology Publishes Post-Hoc Analysis of Tavalisse for Adults with Chronic Immune...
The COVID-19 global pandemic is biting harder by the day, and it seems like it is here to stay. Hence there remains a serious...
Halozyme Therapeutics Inc. (NASDAQ: HALO) Announces That Janssen Biotech Has Received Approval For DARZALEK...
Halozyme Therapeutics Inc. (NASDAQ: HALO) has announced that the US FDA has granted Janssen Biotech Inc. approval for DARZALEK FASPRO in combination with kyprolis...
Unusual call activity (GIS, DBX, DDOG, X)
The stock market has opened up today on a positive note. Wall Street is currently eyeing SPY January 6 $324 Calls. If...
Oncolytics Biotech, Inc. (NASDAQ:ONCY) Commences TNBC Study To Investigate The Use Of Pelareorep Along...
Oncolytics Biotech, Inc. (NASDAQ:ONCY) begins TNBC (triple-negative breast cancer) study, which is sponsored by the investigator. New Jersey-based Rutgers Cancer Institute (RCI) will manage...
MAKE IT MODERN
POPULAR
[/tdc_zone]